title: Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels.
authors.affiliation: Department of Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Altrichter
authors.affiliation: Department of Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Hawro
authors.affiliation: Department of Dermatology and Allergology, Medical School RWTH Aachen University, Aachen, Germany.|Medical School RWTH Aachen University, Institute of Biochemistry and Molecular Biology, Aachen, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Hänel
authors.affiliation: Department of Dermatology and Allergology, Medical School RWTH Aachen University, Aachen, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Czaja
authors.affiliation: Medical School RWTH Aachen University, Institute of Biochemistry and Molecular Biology, Aachen, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Lüscher
authors.affiliation: Department of Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Maurer
authors.affiliation: Department of Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
authors.forename: M K
authors.identifier: http://orcid.org/0000-0002-1639-9410
authors.initials: MK
authors.lastname: Church
authors.affiliation: Department of Dermatology and Allergology, Medical School RWTH Aachen University, Aachen, Germany.
authors.forename: J M
authors.initials: JM
authors.lastname: Baron
mesh_terms: D018926:Anti-Allergic Agents / Q000008:administration & dosage; D015415:Biomarkers / Q000097:blood; D002908:Chronic Disease; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D007378:Interleukins / Q000097:blood*; D000069444:Omalizumab / Q000008:administration & dosage*; D012867:Skin / Q000473:pathology*; D014581:Urticaria / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D015415:Biomarkers; C502187:IL31 protein, human; D007378:Interleukins; D000069444:Omalizumab